GemPharmatech’s Post

View organization page for GemPharmatech, graphic

4,802 followers

📢 Discover cutting-edge non-alcoholic steatohepatitis (NASH) models for your #preclinical studies! As the incidence of NASH continues to rise, the selection of an appropriate NASH model is crucial for developing new treatments. Here at #GemPharmatech, we provide diverse NASH models. We offer genetically engineered mouse models with specific gene deletions (such as BKS-db NASH and B6-Alms1-del NASH), which have a more stable phenotype than the traditional induction model. We also provide a number of humanized mice that target NASH treatment targets (STK25, PNPLA3, DGAT2, and KHK) to support your drug development needs. Learn more here: https://lnkd.in/gASvT37v 🔗 BKS-db NASH: https://lnkd.in/gcJE6fRh 🔗 B6-Alms1-del NASH: https://lnkd.in/gjg2aRRR   #nonalcoholicsteatohepatitis #NASH #Research #NAFLD #antiNASHdrug #drugdevelopment #MetabolicDisease #mousemodel #NASHtreatment #biotech

Non-Alcoholic Steatohepatitis (NASH) Models and Services for Preclinical Studies

Non-Alcoholic Steatohepatitis (NASH) Models and Services for Preclinical Studies

en.gempharmatech.com

To view or add a comment, sign in

Explore topics